CHMP recommends new single-pill combination therapy to treat type 2 diabetes
30 March 2015 The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended Boehringer Ingelheim (BI) and Eli...
Merck KGaA to tap Oschmann as new CEO
Merck KGaA is the latest company to join Big Pharma's recent round of executive musical chairs. The German drugmaker is promoting deputy chief executive...
GSK’s new chairman Hampton to take charge in May
GlaxoSmithKline said on Thursday that its chairman-designate Philip Hampton would take charge of Britain's biggest drugmaker from May 7, an earlier transition than initially...
New test to predict the effectiveness of cancer vaccines
Cancer vaccines are designed to turn the body's own immune system specifically against tumor cells. Particularly promising are vaccines that are directed against so-called...
HYD Pharma to test a new cancer drug
Hungarian pharmaceutical company HYD Pharma has just completed a HUF 250 mln research phase in the development of a new drug for cancer patients,...
GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK
GlaxoSmithKline (GSK) unveiled plans for the construction of a new biopharmaceutical plant in the UK in February 2014. The new facility will...
Ireland’s Government is to invest €5m over the next five years in a new Pharmaceutical Manufacturing Technology
Ireland’s Government is to invest €5m over the next five years in a new Pharmaceutical Manufacturing Technology Centre (PMTC) that will be headquartered at...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...